CClinicalTrials.gg
Not yet recruitingNCT06940245Updated Apr 23, 2025

Use of Virtual Reality for the Assessment of Attentional and Reaction Abilities for Fall Risk Evaluation

An observational study in Aging, Fall Risk Factors and Sleep, sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. Not yet recruiting. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-23.

Sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
60 Years and older
Sex
All
01

Study summary

Aging is a condition characterized by a general decline in physical and cognitive performance, however its effects on various functions are still controversial. These changes lead to an increased risk of injuries, particularly due to falls. According to the World Health Organization (WHO) report, 28-35% of individuals aged over 65 experience a fall each year, and this percentage increases with age. For this reason, preventing falls among the elderly is undeniably one of the most critical public health issues in today's aging society. Nowadays, it is widely demonstrated that the loss of muscle strength and mass, along with decreased balance, significantly increases the risk of falls. However, with aging, numerous other changes occur that contribute to an increased risk of falls, such as a decline in cognitive function, including attention, reaction capabilities and memory, as well as other factors that worsen the quality of life, such as insufficient sleep or nutrition. According to WHO estimates, by 2030, the number of injuries due to falls will double. Therefore, it is of great importance to understand and analyze the factors contributing to falls among older adults in everyday life. For this reason, the principal aim of this study was to evaluate the correlation between the fall index and the Visual Attention, Reaction Time and visual field using the technologies of Virtual Reality (VR). Since aging brigs changes in different aspect, the secondary objectives aim to study the correlation also with i) sleep quantity and quality parameters, ii) risk of malnutrition, and iii) physical condition, muscle conditions and strength in order to have a comprehensive understanding of the factors that most contribute to the risk of falls. In addition to these objectives, the correlation between acute sleep deprivation and the risk of falls will also be analyzed, in order to understand how inadequate sleep quantity can impact injuries in the elderly.

02

Conditions studied

  • Aging
  • Fall Risk Factors
  • Sleep
03

In context

Lead sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio is the lead sponsor of 157 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

A minimum of 100 subjects aged 60 years or older will be recruited, but recruitment will continue until enough subjects are identified to reach the predetermined number for the second study. The subjects are chosen on the basis of the following inclusion and exclusion criteria

Inclusion criteria

  • Male or female, of any ethnicity;
  • Age ≥ 60 years;
  • Cognitively intact;
  • Autonomous ambulation;
  • Signed and accepted informed consent to participate in all procedures required for the study.

Exclusion criteria

Exclusion Criteria:

  • Body Mass Index > 40.0;
  • History of epileptic episodes;
  • Bone fractures in the last 6 months;
  • Previous surgical treatments for orthopedic conditions performed in the six months prior to study inclusion;
  • Use of medications that affect motor coordination, balance, and bone and muscle metabolism;
  • Conditions that, despite autonomous ambulation, influence fall risk (e.g., orthopedic, rheumatologic, or neurological conditions);
  • Carriers of pacemakers and mechanical implants.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Target follow-up
2 Weeks
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. 30 - second chair stand test

    to assess the leg strength and endurance in older adults. Being in a specific sitting position on a chair, the test consists of getting up and sitting down as many times as possible in 30 seconds

    Time frame: 10 days ± 3 days after the familiarization day

Secondary outcomes

  1. Virtual reality (VR-Brain Tracker)

    Evaluation to assess visual attention through the Multiple Object Tracking paradigm.

    Time frame: 10 days ± 3 days after the familiarization day

  2. Strength asessment

    Handgrip Test (Kg) Flexors and Extensors of thigh muscles (Kg)

    Time frame: 10 days ± 3 days after the familiarization day

  3. Balance test

    balance assessment is conducted using Baiobit equipment from BTS Bioengineering. The maximal balance time in monopodalic will be considered (s)

    Time frame: 10 days ± 3 days after the familiarization day

  4. Sleep assessment

    Objective assessment of sleep quantity and quality using the MotionWatch 8® (CamTec, USA), and sleep diary.

    Time frame: sleep monitoring duration: 10 days ± 3 days after the familiarization day

  5. Sleep Hygene Index

    Questionnaire to assess the sleep hygene

    Time frame: 10 days ± 3 days after the familiarization day

  6. Body Impedence Assessment

    to assess body composition by measuring the resistance of electrical flow through the body. It helps estimate parameters like body fat percentage, muscle mass, and water content. BIA is commonly used in health and fitness settings to monitor changes in body composition, guide nutritional and fitness plans, and assess overall health.

    Time frame: T1

  7. Virtual reality (CNS Sprint)

    To assess the response time (ms)

    Time frame: 10 days ± 3 days after the familiarization day

  8. Virtual reality (Visual efficiency)

    To assess the visual field

    Time frame: 10 days ± 3 days after the familiarization day

  9. The Pittsburgh Sleep Quality Index

    Questionnaire to assess sleep quality

    Time frame: 10 days ± 3 days after the familiarization day

  10. Morningness-Eveningness Questionnaire

    Questionnaire to assess the chronotype

    Time frame: 10 days ± 3 days after the familiarization day

  11. Karolinska Sleepiness Scale

    Scale to assess the sleepiness

    Time frame: 10 days ± 3 days after the familiarization day

  12. Tiredness Severity Scale

    Scale to assess the tiredness

    Time frame: 10 days ± 3 days after the familiarization day

  13. SARC-F

    A QUESTIONNAIRE FOR SCREENING THE RISK OF SARCOPENIA

    Time frame: 10 days ± 3 days after the familiarization day

  14. International Physical Activity Questionnaire

    Questionnaire to assess the physical activity

    Time frame: 10 days ± 3 days after the familiarization day

  15. BORG-CR10 scale

    EFFORT PERCEPTION SCALE

    Time frame: 10 days ± 3 days after the familiarization day

  16. Mini Nutritional Assessment

    QUESTIONNAIRE TO ASSESS THE RISK OF MALNUTRITION

    Time frame: 10 days ± 3 days after the familiarization day

  17. Nutritional diary

    Keeping a food diary helps collect accurate data on participants' eating habits for scientific analysis.

    Time frame: 10 days ± 3 days after the familiarization day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06940245
Lead sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Responsible party
Sponsor
First posted
Apr 23, 2025
Start date
Apr 20, 2025 (estimated)
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Apr 23, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion